[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fJ2rYEUbW8Da10H59L2ihQtCqASc1HnlkVE07QNN0Luw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Christiana Care Health Services",[4],93,false,4,1,13337,0,73,[14,17,20,22,24,26,28,31],{"name":15,"count":16},"Sepsis",5,{"name":18,"count":19},"Prematurity",3,{"name":21,"count":19},"Obesity",{"name":23,"count":19},"Thrombocytopenia",{"name":25,"count":19},"Premature Birth",{"name":27,"count":19},"Preterm Birth",{"name":29,"count":30},"Preeclampsia Severe",2,{"name":32,"count":30},"Pre-Eclampsia",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,72,90,118,136,154,180,207,233,258,283,310,337,366,403,439,465,491,515,533,560,578,603],{"intervention":43,"totalTrials":9,"cells":44},"Metformin",{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":70},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":60,"start":61,"enrollment":8,"conditions":62,"interventions":68},"NCT06359015","Metformin and Esomeprazole in Preterm Pre-eclampsia","TERMINATED",[39],"2025-05-08","2021-02-11",[29,32,63,64,65,66,67],"Preeclampsia","Preeclampsia Second Trimester","Preeclampsia Complicating Childbirth","Preeclampsia Puerperium","Preterm",[43,69],"Esomeprazole",{"trials":71,"activeCount":11},[],{"intervention":69,"totalTrials":9,"cells":73},{"EARLY_PHASE1":74,"PHASE1":76,"PHASE2":78,"PHASE3":80,"PHASE4":82,"NA":88},{"trials":75,"activeCount":11},[],{"trials":77,"activeCount":11},[],{"trials":79,"activeCount":11},[],{"trials":81,"activeCount":11},[],{"trials":83,"activeCount":11},[84],{"nctId":56,"briefTitle":57,"status":58,"phases":85,"primaryCompletion":60,"completion":60,"start":61,"enrollment":8,"conditions":86,"interventions":87},[39],[29,32,63,64,65,66,67],[43,69],{"trials":89,"activeCount":11},[],{"intervention":91,"totalTrials":9,"cells":92},"Gabapentin",{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":116},{"trials":94,"activeCount":11},[],{"trials":96,"activeCount":11},[],{"trials":98,"activeCount":11},[],{"trials":100,"activeCount":11},[],{"trials":102,"activeCount":11},[103],{"nctId":104,"briefTitle":105,"status":106,"phases":107,"primaryCompletion":108,"completion":108,"start":109,"enrollment":110,"conditions":111,"interventions":113},"NCT02703259","Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management","COMPLETED",[39],"2017-07","2016-06",137,[112],"Pain, Postoperative",[91,114,115],"Acetaminophen","Celecoxib",{"trials":117,"activeCount":11},[],{"intervention":114,"totalTrials":9,"cells":119},{"EARLY_PHASE1":120,"PHASE1":122,"PHASE2":124,"PHASE3":126,"PHASE4":128,"NA":134},{"trials":121,"activeCount":11},[],{"trials":123,"activeCount":11},[],{"trials":125,"activeCount":11},[],{"trials":127,"activeCount":11},[],{"trials":129,"activeCount":11},[130],{"nctId":104,"briefTitle":105,"status":106,"phases":131,"primaryCompletion":108,"completion":108,"start":109,"enrollment":110,"conditions":132,"interventions":133},[39],[112],[91,114,115],{"trials":135,"activeCount":11},[],{"intervention":115,"totalTrials":9,"cells":137},{"EARLY_PHASE1":138,"PHASE1":140,"PHASE2":142,"PHASE3":144,"PHASE4":146,"NA":152},{"trials":139,"activeCount":11},[],{"trials":141,"activeCount":11},[],{"trials":143,"activeCount":11},[],{"trials":145,"activeCount":11},[],{"trials":147,"activeCount":11},[148],{"nctId":104,"briefTitle":105,"status":106,"phases":149,"primaryCompletion":108,"completion":108,"start":109,"enrollment":110,"conditions":150,"interventions":151},[39],[112],[91,114,115],{"trials":153,"activeCount":11},[],{"intervention":155,"totalTrials":9,"cells":156},"Clindamycin",{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":178},{"trials":158,"activeCount":11},[],{"trials":160,"activeCount":11},[],{"trials":162,"activeCount":11},[],{"trials":164,"activeCount":11},[],{"trials":166,"activeCount":11},[167],{"nctId":168,"briefTitle":169,"status":106,"phases":170,"primaryCompletion":171,"completion":171,"start":172,"enrollment":173,"conditions":174,"interventions":177},"NCT01800825","Clindamycin to Reduce Preterm Birth in a Low Resource Setting",[39],"2016-04","2013-07",1726,[175,18,27,176],"Pregnancy","Bacterial Vaginosis",[155],{"trials":179,"activeCount":11},[],{"intervention":181,"totalTrials":9,"cells":182},"Nitrous Oxide",{"EARLY_PHASE1":183,"PHASE1":185,"PHASE2":187,"PHASE3":189,"PHASE4":191,"NA":205},{"trials":184,"activeCount":11},[],{"trials":186,"activeCount":11},[],{"trials":188,"activeCount":11},[],{"trials":190,"activeCount":11},[],{"trials":192,"activeCount":11},[193],{"nctId":194,"briefTitle":195,"status":196,"phases":197,"primaryCompletion":198,"completion":199,"start":200,"enrollment":11,"conditions":201,"interventions":204},"NCT02703233","Effectiveness of Nitrous Oxide in the ED","WITHDRAWN",[39],"2018-03","2018-06","2016-03",[202,203],"Lacerations","Abscess",[181],{"trials":206,"activeCount":11},[],{"intervention":208,"totalTrials":9,"cells":209},"Glutamine",{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":229,"NA":231},{"trials":211,"activeCount":11},[],{"trials":213,"activeCount":11},[],{"trials":215,"activeCount":11},[],{"trials":217,"activeCount":11},[218],{"nctId":219,"briefTitle":220,"status":58,"phases":221,"primaryCompletion":222,"completion":222,"start":223,"enrollment":224,"conditions":225,"interventions":228},"NCT00318331","Enteral Glutamine in Critical Illness",[37,38],"2007-09","2006-05",20,[226,15,227],"Critical Illness","Respiratory Insufficiency",[208],{"trials":230,"activeCount":11},[],{"trials":232,"activeCount":11},[],{"intervention":234,"totalTrials":9,"cells":235},"Ascorbic Acid",{"EARLY_PHASE1":236,"PHASE1":238,"PHASE2":240,"PHASE3":252,"PHASE4":254,"NA":256},{"trials":237,"activeCount":11},[],{"trials":239,"activeCount":11},[],{"trials":241,"activeCount":11},[242],{"nctId":243,"briefTitle":244,"status":58,"phases":245,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":251},"NCT02734147","High Dose Intravenous Ascorbic Acid in Severe Sepsis",[37],"2017-10-08","2017-11-23","2016-04-01",24,[15],[234],{"trials":253,"activeCount":11},[],{"trials":255,"activeCount":11},[],{"trials":257,"activeCount":11},[],{"intervention":259,"totalTrials":9,"cells":260},"Carboplatin, Pemetrexed and Bevacizumab",{"EARLY_PHASE1":261,"PHASE1":263,"PHASE2":265,"PHASE3":277,"PHASE4":279,"NA":281},{"trials":262,"activeCount":11},[],{"trials":264,"activeCount":11},[],{"trials":266,"activeCount":11},[267],{"nctId":268,"briefTitle":269,"status":106,"phases":270,"primaryCompletion":271,"completion":271,"start":272,"enrollment":273,"conditions":274,"interventions":276},"NCT00614822","Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer",[37],"2016-08-22","2007-11",50,[275],"Non Small Cell Lung Cancer",[259],{"trials":278,"activeCount":11},[],{"trials":280,"activeCount":11},[],{"trials":282,"activeCount":11},[],{"intervention":284,"totalTrials":9,"cells":285},"Propranolol",{"EARLY_PHASE1":286,"PHASE1":288,"PHASE2":302,"PHASE3":304,"PHASE4":306,"NA":308},{"trials":287,"activeCount":11},[],{"trials":289,"activeCount":11},[290],{"nctId":291,"briefTitle":292,"status":106,"phases":293,"primaryCompletion":294,"completion":295,"start":296,"enrollment":297,"conditions":298,"interventions":301},"NCT04741698","Propranolol for Protracted Labor",[36],"2022-06-11","2022-07-01","2021-07-27",80,[299,300],"Labour;Obstructed","Labor Dystocia",[284],{"trials":303,"activeCount":11},[],{"trials":305,"activeCount":11},[],{"trials":307,"activeCount":11},[],{"trials":309,"activeCount":11},[],{"intervention":311,"totalTrials":9,"cells":312},"Esomeprazole 20mg",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":329,"PHASE3":331,"PHASE4":333,"NA":335},{"trials":314,"activeCount":11},[],{"trials":316,"activeCount":11},[317],{"nctId":318,"briefTitle":319,"status":320,"phases":321,"primaryCompletion":322,"completion":323,"start":324,"enrollment":325,"conditions":326,"interventions":328},"NCT05232994","Metformin and Esomeprazole For Preterm Pre-eclampsia","UNKNOWN",[36],"2024-12-31","2025-12-31","2023-03-01",38,[29,64,327],"Preterm Birth Complication",[311],{"trials":330,"activeCount":11},[],{"trials":332,"activeCount":11},[],{"trials":334,"activeCount":11},[],{"trials":336,"activeCount":11},[],{"intervention":338,"totalTrials":9,"cells":339},"Topotecan and pegylated doxorubicin",{"EARLY_PHASE1":340,"PHASE1":342,"PHASE2":358,"PHASE3":360,"PHASE4":362,"NA":364},{"trials":341,"activeCount":11},[],{"trials":343,"activeCount":11},[344],{"nctId":345,"briefTitle":346,"status":106,"phases":347,"primaryCompletion":348,"completion":349,"start":350,"enrollment":224,"conditions":351,"interventions":357},"NCT00252889","Doxil Topotecan Doublet Cancer Study",[36],"2006-03","2008-06","2004-05",[352,353,354,355,356],"Small Cell Lung Cancer","Pancreatic Cancer","Head and Neck Cancer","Gastric Cancer","Esophageal Cancer",[338],{"trials":359,"activeCount":11},[],{"trials":361,"activeCount":11},[],{"trials":363,"activeCount":11},[],{"trials":365,"activeCount":11},[],{"intervention":367,"totalTrials":30,"cells":368},"Misoprostol",{"EARLY_PHASE1":369,"PHASE1":393,"PHASE2":395,"PHASE3":397,"PHASE4":399,"NA":401},{"trials":370,"activeCount":11},[371,382],{"nctId":372,"briefTitle":373,"status":106,"phases":374,"primaryCompletion":375,"completion":376,"start":377,"enrollment":378,"conditions":379,"interventions":381},"NCT03976037","Buccal Versus Vaginal Misoprostol In Combination With Foley Bulb",[35],"2020-01-20","2021-02-01","2019-06-04",216,[380],"Induction of Labor",[367],{"nctId":383,"briefTitle":384,"status":106,"phases":385,"primaryCompletion":386,"completion":387,"start":388,"enrollment":389,"conditions":390,"interventions":392},"NCT04496908","Early Versus Delayed Artificial Rupture of Membranes (AROM Trial)",[35],"2021-05-22","2021-10-18","2020-09-16",160,[391],"Induction of Labor Affected Fetus \u002F Newborn",[367],{"trials":394,"activeCount":11},[],{"trials":396,"activeCount":11},[],{"trials":398,"activeCount":11},[],{"trials":400,"activeCount":11},[],{"trials":402,"activeCount":11},[],{"intervention":404,"totalTrials":30,"cells":405},"Oxytocin",{"EARLY_PHASE1":406,"PHASE1":408,"PHASE2":410,"PHASE3":412,"PHASE4":414,"NA":426},{"trials":407,"activeCount":11},[],{"trials":409,"activeCount":11},[],{"trials":411,"activeCount":11},[],{"trials":413,"activeCount":11},[],{"trials":415,"activeCount":11},[416],{"nctId":417,"briefTitle":418,"status":106,"phases":419,"primaryCompletion":420,"completion":420,"start":421,"enrollment":422,"conditions":423,"interventions":425},"NCT02273115","Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor",[39],"2016-09-11","2014-10",323,[424],"Labor; Forced or Induced, Affecting Fetus or Newborn",[404],{"trials":427,"activeCount":11},[428],{"nctId":429,"briefTitle":430,"status":106,"phases":431,"primaryCompletion":432,"completion":432,"start":433,"enrollment":434,"conditions":435,"interventions":437},"NCT00473707","Active Versus Expectant Management of the Third Stage of Labor",[40],"2006-07","2002-08",218,[436],"Postpartum Hemorrhage",[438,404],"Oxytocin and gentle cord traction with fundal massage",{"intervention":440,"totalTrials":9,"cells":441},"Aliskiren",{"EARLY_PHASE1":442,"PHASE1":444,"PHASE2":446,"PHASE3":448,"PHASE4":450,"NA":452},{"trials":443,"activeCount":11},[],{"trials":445,"activeCount":11},[],{"trials":447,"activeCount":11},[],{"trials":449,"activeCount":11},[],{"trials":451,"activeCount":11},[],{"trials":453,"activeCount":11},[454],{"nctId":455,"briefTitle":456,"status":106,"phases":457,"primaryCompletion":458,"completion":459,"start":460,"enrollment":461,"conditions":462,"interventions":464},"NCT00935064","The Effect of Renin Inhibition on Nerve Function in Diabetes",[40],"2011-10","2012-04","2009-06",60,[463],"Diabetes",[440],{"intervention":466,"totalTrials":9,"cells":467},"Intravenous fluid",{"EARLY_PHASE1":468,"PHASE1":470,"PHASE2":472,"PHASE3":474,"PHASE4":476,"NA":478},{"trials":469,"activeCount":11},[],{"trials":471,"activeCount":11},[],{"trials":473,"activeCount":11},[],{"trials":475,"activeCount":11},[],{"trials":477,"activeCount":11},[],{"trials":479,"activeCount":11},[480],{"nctId":481,"briefTitle":482,"status":106,"phases":483,"primaryCompletion":484,"completion":485,"start":486,"enrollment":487,"conditions":488,"interventions":490},"NCT01449721","Preemptive Resuscitation for Eradication of Septic Shock",[40],"2015-01","2016-01","2011-09",142,[15,489],"Severe Sepsis",[466],{"intervention":492,"totalTrials":9,"cells":493},"Chlorhexidine gluconate",{"EARLY_PHASE1":494,"PHASE1":496,"PHASE2":498,"PHASE3":500,"PHASE4":502,"NA":504},{"trials":495,"activeCount":11},[],{"trials":497,"activeCount":11},[],{"trials":499,"activeCount":11},[],{"trials":501,"activeCount":11},[],{"trials":503,"activeCount":11},[],{"trials":505,"activeCount":11},[506],{"nctId":507,"briefTitle":508,"status":106,"phases":509,"primaryCompletion":510,"completion":510,"start":349,"enrollment":511,"conditions":512,"interventions":514},"NCT00779246","Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections",[40],"2009-07",1518,[513],"Staphylococcal Infections",[492],{"intervention":438,"totalTrials":9,"cells":516},{"EARLY_PHASE1":517,"PHASE1":519,"PHASE2":521,"PHASE3":523,"PHASE4":525,"NA":527},{"trials":518,"activeCount":11},[],{"trials":520,"activeCount":11},[],{"trials":522,"activeCount":11},[],{"trials":524,"activeCount":11},[],{"trials":526,"activeCount":11},[],{"trials":528,"activeCount":11},[529],{"nctId":429,"briefTitle":430,"status":106,"phases":530,"primaryCompletion":432,"completion":432,"start":433,"enrollment":434,"conditions":531,"interventions":532},[40],[436],[438,404],{"intervention":534,"totalTrials":9,"cells":535},"Saline",{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":540,"PHASE3":542,"PHASE4":544,"NA":546},{"trials":537,"activeCount":11},[],{"trials":539,"activeCount":11},[],{"trials":541,"activeCount":11},[],{"trials":543,"activeCount":11},[],{"trials":545,"activeCount":11},[],{"trials":547,"activeCount":11},[548],{"nctId":549,"briefTitle":550,"status":58,"phases":551,"primaryCompletion":552,"completion":553,"start":554,"enrollment":555,"conditions":556,"interventions":558},"NCT00541671","Prevention of Narcotic-Induced Nausea",[40],"2009-09","2009-11","2007-02",25,[557],"Nausea",[534,559],"Phenergan",{"intervention":559,"totalTrials":9,"cells":561},{"EARLY_PHASE1":562,"PHASE1":564,"PHASE2":566,"PHASE3":568,"PHASE4":570,"NA":572},{"trials":563,"activeCount":11},[],{"trials":565,"activeCount":11},[],{"trials":567,"activeCount":11},[],{"trials":569,"activeCount":11},[],{"trials":571,"activeCount":11},[],{"trials":573,"activeCount":11},[574],{"nctId":549,"briefTitle":550,"status":58,"phases":575,"primaryCompletion":552,"completion":553,"start":554,"enrollment":555,"conditions":576,"interventions":577},[40],[557],[534,559],{"intervention":579,"totalTrials":9,"cells":580},"Vancomycin",{"EARLY_PHASE1":581,"PHASE1":583,"PHASE2":585,"PHASE3":587,"PHASE4":589,"NA":591},{"trials":582,"activeCount":11},[],{"trials":584,"activeCount":11},[],{"trials":586,"activeCount":11},[],{"trials":588,"activeCount":11},[],{"trials":590,"activeCount":11},[],{"trials":592,"activeCount":11},[593],{"nctId":594,"briefTitle":595,"status":106,"phases":596,"primaryCompletion":597,"completion":597,"start":598,"enrollment":599,"conditions":600,"interventions":602},"NCT01162733","Loading Vancomycin Doses in the Emergency Department",[40],"2012-06","2010-07",99,[601],"Infectious Disease",[579,579],{"intervention":604,"totalTrials":9,"cells":605},"Bupivacaine",{"EARLY_PHASE1":606,"PHASE1":608,"PHASE2":610,"PHASE3":612,"PHASE4":614,"NA":616},{"trials":607,"activeCount":11},[],{"trials":609,"activeCount":11},[],{"trials":611,"activeCount":11},[],{"trials":613,"activeCount":11},[],{"trials":615,"activeCount":11},[],{"trials":617,"activeCount":11},[618],{"nctId":619,"briefTitle":620,"status":106,"phases":621,"primaryCompletion":622,"completion":622,"start":171,"enrollment":623,"conditions":624,"interventions":626},"NCT02660918","Decreasing Postoperative Pain Following Endometrial Ablation",[40],"2017-03",84,[625],"Postoperative Pain",[604]]